Predictive value of the Lung Immune Prognostic Index (LIPI) in locally advanced non-small-cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) in the multicenter retrospective study.

被引：0
|
作者：
Oya, Yuko
Saito, Go
Tamiya, Akihiro
Kawachi, Hayato
Fujimoto, Daichi
Iwasawa, Shunichiro
Suzuki, Hidekazu
Niitsu, Takayuki
Matsumoto, Hirotaka
Miyauchi, Eisaku
Yokoi, Takashi
Mitsui, Miho
Uenami, Takeshi
Sakata, Yoshihiko
Nakachi, Ichiro
Okada, Asuka
Hara, Satoshi
Teraoka, Shunsuke
Kokubo, Masaki
机构：
[1] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan
[2] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan
[3] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Internal Med, Sakai, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan
[5] Gen Hosp, Kobe City Med Ctr, Dept Resp Med, Kobe, Hyogo, Japan
[6] Chiba Univ, Dept Med Oncol, Chiba, Japan
[7] Osaka Habikino Med Ctr, Dept Thorac Oncol, Habikino, Japan
[8] Osaka Gen Med Ctr, Dept Resp Med, Osaka, Japan
[9] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[10] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan
[11] Hyogo Coll Med, Dept Thorac Oncol, Nishinomiya, Hyogo, Japan
[12] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan
[13] Natl Hosp Org Osaka Toneyama Med Ctr, Dept Thorac Oncol, Osaka, Japan
[14] Saiseikai Kumamoto Hosp, Div Resp Med, Kumamoto, Japan
[15] Saiseikai Utsunomiya Hosp, Internal Med, Pulm Div, Utsunomiya, Tochigi, Japan
[16] Saiseikai Suita Hosp, Dept Resp Med, Osaka, Japan
[17] Itami City Hosp, Dept Resp Med, Osaka, Japan
[18] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan
[19] Kobe City Med Ctr, Gen Hosp, Dept Radiat Oncol, Kobe, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21076
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy
    Shien, Kazuhiko
    Toyooka, Shinichi
    Soh, Junichi
    Hotta, Katsuyuki
    Katsui, Kuniaki
    Oto, Takahiro
    Kanazawa, Susumu
    Kiura, Katsuyuki
    Date, Hiroshi
    Miyoshi, Shinichiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 706 - 712
  • [22] Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Wink, Krista
    Belderbos, Jose
    Dieleman, Edith
    Rossi, Maddalena
    Rasch, Coen
    Damhuis, Ronald
    Houben, Ruud
    Troost, Esther
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S278 - S279
  • [23] Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer
    Kishida, Yukiko
    Hirose, Takashi
    Shirai, Takao
    Sugiyama, Tomohide
    Kusumoto, Soujiro
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Adachi, Mitsuru
    Nakamura, Akihiro
    ONCOLOGY LETTERS, 2011, 2 (05) : 949 - 955
  • [24] Definitive concurrent chemoradiotherapy for patients over 75 years old with locally advanced non-small-cell lung cancer
    Kishi, T.
    Kokubo, M.
    Shintani, T.
    Uto, M.
    Kosaka, Y.
    Takayama, K.
    Tomi, K.
    Katakami, N.
    Hiraoka, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S805 - S805
  • [25] Applicability of lung immune prognostic index (LIPI) to predict efficacy of first-line pembrolizumab in advanced non-small cell lung cancer (NSCLC)
    Mielgo Rubio, X.
    Gomez Rueda, A.
    Antonanzas, M.
    Falagan, S.
    Nunez, J. A.
    Pena, A. M. Sanchez
    Gomez-Barreda, I.
    Martinez Moreno, E.
    Cerezo Gonzalez, S.
    Cabezon Gutierrez, L.
    Sanchez Torres, J. M.
    Jimenez Munarriz, B. E.
    Cervera, R.
    Pangua Mendez, C.
    Calles Blanco, A.
    Lopez Martin, A.
    Lopez Castro, R.
    Sotelo Lezama, M. J.
    Perez Fernandez, E.
    Cruz, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with concurrent radiotherapy and gemcitabine
    Michel, Rosa M.
    Gallardo-Rincon, Dolores
    Villarreal-Garza, Cynthia
    Astorga-Ramos, Alma
    Zamora, Jesus
    Martinez-Barrera, Luis
    de la Garza, Jaime
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S846 - S847
  • [27] Geriatric assessment to predict toxicity in elderly patients with unresectable locally advanced non-small-cell lung cancer treated with concurrent chemoradiotherapy.
    Nadal, Ernest
    Carlos Ruffinelli, Jose
    Palmero, Ramon
    Navarro, Arturo
    Plana, Maria
    Mesia Barroso, Carlos
    Dolores Arnaiz, Maria
    Brao, Isabel
    Arellano, Monica
    Padrones, Susana
    Borras, Josep Maria
    Cardenal, Felipe
    Saldana, Juana
    Antonio Rebollo, Maite
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer
    Giorgio, Carmelo G.
    Pappalardo, Alessandro
    Russo, Antonio
    Santini, Daniele
    Di Rosa, Carlo
    Di Salvo, Carmela
    Castorina, Sergio
    Marletta, Franco
    Bellissima, Giuseppe
    Palermo, Nuccio
    Scuderi, Concetto
    Bordonaro, Roberto
    ANTI-CANCER DRUGS, 2007, 18 (06) : 713 - 719
  • [29] Neoadjuvant chemotherapy and chemoradiotherapy for locally advanced non small cell lung cancer (NSCLC)
    Gavila, Q
    Almendros, P
    Camps, C
    López-Torrecillas, J
    Safont, M
    Blasco, A
    Garde, J
    Juarez, A
    Iranzo, V
    Sirera, R
    LUNG CANCER, 2005, 49 : S379 - S380
  • [30] Prognostic value of prognostic nutritional index and its variations in advanced non-small-cell lung cancer patients treated with anlotinib monotherapy
    Chen, Tian
    Liang, Gaofeng
    Xiang, Zhenfei
    He, Jinxian
    Xu, Xiaoyu
    Tang, Mengqiu
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (04)
12345